Substrate-Dependent Ligand Inhibition of the Human Organic Cation Transporter OCT2

Journal of Pharmacology and Experimental Therapeutics - Tập 346 Số 2 - Trang 300-310 - 2013
Mathew Belzer1, Mark Morales1, B. Jagadish1, Eugene A. Mash1, Stephen H. Wright1
1Departments of Physiology (M.B., M.M., S.H.W.) and Chemistry (B.J., E.A.M.), University of Arizona, Tucson, Arizona

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1080/00397910500446597

10.1021/jm8003152

10.1126/science.1168750

10.1016/j.neuropharm.2006.01.005

10.1002/pds.1351

10.1124/mol.63.3.489

Bednarczyk, 2000, NBD-TMA: a novel fluorescent substrate of the peritubular organic cation transporter of renal proximal tubules, Pflugers Arch, 440, 184, 10.1007/s004240000283

10.1074/jbc.M112.388793

10.1124/mol.61.5.974

10.1016/j.ejps.2005.11.002

10.1124/mol.62.6.1288

10.1038/nrd3028

10.1124/mol.56.6.1254

Groves, 1994, Peritubular organic cation transport in isolated rabbit proximal tubules, Am J Physiol, 266, F450

10.1152/ajprenal.00486.2012

10.1021/jm2001629

10.1152/ajprenal.90754.2008

10.1517/17425255.2012.667401

Lin, 1991, Time-resolved fluorescence of nitrobenzoxadiazole-aminohexanoic acid: effect of intermolecular hydrogen-bonding on non-radiative decay, Photochem Photobiol, 54, 361, 10.1111/j.1751-1097.1991.tb02028.x

10.1007/BF01872636

10.1124/jpet.108.146225

Moaddel, 2007, Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1), Br J Pharmacol, 151, 1305, 10.1038/sj.bjp.0707341

Motohashi, 2002, Gene expression levels and immunolocalization of organic ion transporters in the human kidney, J Am Soc Nephrol, 13, 866, 10.1681/ASN.V134866

10.1016/j.bcp.2005.09.011

10.1023/A:1025032511040

10.1007/978-3-642-14541-4_3

10.1152/ajprenal.00038.2012

10.1152/ajprenal.00496.2006

10.1074/jbc.M606561200

10.1124/mol.104.008839

10.1124/dmd.110.036640

Schumacher, 2003, Deciphering the molecular basis of multidrug recognition: crystal structures of the Staphylococcus aureus multidrug binding transcription regulator QacR, Res Microbiol, 154, 69, 10.1016/S0923-2508(02)00013-X

Segel IH (1975) Enzyme Kinetics, pp 100–135, John Wiley & Sons, New York.

Sissung, 2012, Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy, Discov Med, 13, 19

10.1124/mol.104.004713

10.1124/jpet.105.088104

Thummel KE Shen DD (2001) Design and optimization of dosage regimens: pharmacokinetic data, in Goodman & Gilman’s: The Pharmacological Basis of Therapeutics ( Hardman JG Limbird LE , eds, ed) pp 1917–2023, McGraw-Hill, New York.

10.1007/s002329900247

10.1124/mol.64.5.1037

10.1124/mol.109.054783

10.1210/en.2009-0769

10.1074/jbc.M112.386979

10.1074/jbc.M506342200

10.1007/s00210-008-0369-5